WSJ
Search documents
ConocoPhillips Posts Weaker Profit on Lower Prices
WSJ· 2026-02-05 12:44
Core Insights - ConocoPhillips' fourth-quarter earnings decreased due to lower prices, although this was slightly mitigated by an increase in production [1] Financial Performance - The decline in earnings was primarily attributed to lower prices in the market [1] - Higher production levels provided a partial offset to the earnings drop [1]
Cardinal Health Lifts Outlook After Posting Higher Profit
WSJ· 2026-02-05 12:35
Group 1 - Cardinal Health raised its outlook for the year following an increase in profit and revenue during its fiscal second quarter [1]
Tapestry Boosts Outlook as Coach Sales Surge
WSJ· 2026-02-05 12:28
Core Insights - Tapestry reported higher second-quarter revenue, indicating strong performance driven by its Coach brand, which helped offset declines in Kate Spade sales [1] Financial Performance - The company raised its fiscal-year outlook, reflecting confidence in continued growth despite challenges faced by the Kate Spade brand [1]
Hershey Profit Dragged Down by Tariffs, Cocoa Costs
WSJ· 2026-02-05 12:26
Hershey reported lower fourth-quarter profit as tariff costs and high cocoa prices continued to hurt its bottom line. ...
Estee Lauder Lifts Outlook, Warns of Tariff Impact
WSJ· 2026-02-05 12:11
Core Insights - Estee Lauder has raised its adjusted earnings outlook for the year, indicating a positive adjustment in financial expectations [1] - The company anticipates that tariff-related challenges will negatively impact its profits by approximately $100 million, primarily affecting the second half of the year [1] Financial Outlook - The adjusted earnings outlook has been lifted, suggesting improved performance expectations for the fiscal year [1] - The expected profit reduction due to tariffs highlights ongoing external economic pressures that could affect overall profitability [1]
Bristol Myers Squibb Revenue Ticks Up on Immuno-Oncology Growth
WSJ· 2026-02-05 12:09
Core Insights - Bristol Myers Squibb reported higher fourth-quarter revenue driven by growth in sales of its immuno-oncology treatments, which helped to offset a decline in revenue from some of its older drugs [1] Group 1 - The increase in revenue is attributed to the success of immuno-oncology treatments [1] - Older drugs experienced a decline in revenue, indicating a potential shift in the company's product performance [1]
KKR to Acquire Pro Sports Investor Arctos in $1.4 Billion Deal
WSJ· 2026-02-05 12:01
KKR agreed to acquire Arctos Partners, an investor in professional sports franchise stakes, in a deal initially valued at $1.4 billion. ...
Amazon Fined in Germany Over Price-Filtering Tools
WSJ· 2026-02-05 11:50
Core Viewpoint - German antitrust officials imposed a fine of approximately $70 million on Amazon.com for breaching competition law through its tools that filter out listings from third-party vendors [1] Group 1 - The fine reflects regulatory scrutiny on major tech companies regarding their market practices [1] - The decision highlights ongoing concerns about competition and fairness in the e-commerce sector [1] - Amazon's practices are under examination as part of broader antitrust investigations in Europe [1]
Barrick Aims for IPO of North American Gold Assets This Year
WSJ· 2026-02-05 11:42
Barrick Mining is pushing ahead with plans to separate its North American gold operations into a separately listed company in which it plans to retain a controlling stake. ...
Spotify, a Major Audiobook Provider, Will Soon Offer Physical Books
WSJ· 2026-02-05 11:30
The streaming service is joining with Bookshop.org to appeal to readers who read in multiple formats. ...